|
1
|
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
|
N Engl J Med
|
2004
|
7.67
|
|
2
|
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
|
Gastroenterology
|
2006
|
2.96
|
|
3
|
Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection.
|
Am J Gastroenterol
|
2010
|
1.56
|
|
4
|
Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.
|
J Immunol
|
2002
|
1.37
|
|
5
|
Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
|
J Immunol
|
2004
|
1.27
|
|
6
|
Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.
|
J Infect Dis
|
2004
|
1.12
|
|
7
|
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
|
J Acquir Immune Defic Syndr
|
2010
|
0.97
|
|
8
|
Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection.
|
AIDS Patient Care STDS
|
2011
|
0.87
|
|
9
|
Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells.
|
J Gen Virol
|
2005
|
0.86
|
|
10
|
Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.
|
Hepatology
|
2012
|
0.80
|
|
11
|
Resolution of chronic hepatitis C following parasitosis.
|
World J Gastroenterol
|
2007
|
0.79
|
|
12
|
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection.
|
Eur J Gastroenterol Hepatol
|
2014
|
0.78
|